🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study was to evaluate the efficacy (blood pressure lower...
Status
Completed
Location
Investigative Site
Start Date
2010-10
Trial ID
NCT01237223
The aim of the study is to find out whether aliskiren reduces atrial fibril...
Status
Unknown
Location
Helsinki University Central Hospital
Start Date
2012-01
Trial ID
NCT02909166
Treatments Being Tested
To demonstrate the efficacy and safety of aliskiren given to patients with ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2004-11
Trial ID
NCT00219089
Treatments Being Tested
This study will measure the effects of different doses of aliskiren on kidn...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2005-10
Trial ID
NCT00518765
Treatments Being Tested
Marfan syndrome (MFS) is an inherited disorder of connective tissue with mo...
Status
Completed
Location
Samsung Medical Center
Start Date
2010-06
Trial ID
NCT01715207
The goal of this proposal is to conduct a pilot study to access the antipro...
Status
Withdrawn
Location
Mayo Clinic in Rochester
Start Date
2010-11
Trial ID
NCT01093781
Treatments Being Tested
This study will evaluate the safety and efficacy of long term treatment of ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2004-10
Trial ID
NCT00246584
Treatments Being Tested
This study evaluated the effect of early initiation of aliskiren therapy, c...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-05
Trial ID
NCT00894387
Study objective: To investigate the potential anti-proteinuric and renoprot...
Status
Completed
Location
Queen Mary Hospital
Start Date
2009-07
Trial ID
NCT01150201
The purpose of the study is to evaluate the blood pressure lowering effect ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2008-11
Trial ID
NCT00797316
Treatments Being Tested